Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Caplin Steriles gets USFDA nod for generic VAZCULEP injection

Ruchika Sharma13 Jun 2020 11:00 AM IST

Phenylephrine Hydrochloride Injection is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the...

Lupin, PlushCare expand access to Bacterial Vaginosis Treatment to Meet Patient Needs amid COVID crisis

Ruchika Sharma13 Jun 2020 9:45 AM IST

"With the current healthcare landscape, more people are turning to telehealth than we've ever seen before," said Ryan McQuaid, CEO, and Co-Founder of...

Eli Lilly COVID-19 drug could be authorized for use in September: Report

Ruchika Sharma13 Jun 2020 9:30 AM IST

A monoclonal antibody drug developed against COVID-19 is likely to be more effective than repurposed medicines currently being tested against the...

Parliamentary Panel Questions Rejection of NIMERs Proposal, Demands Explanation

NIPERs should establish National level testing labs for pharma products for revenue generation: Minister

Ruchika Sharma12 Jun 2020 4:59 PM IST

The Minister suggested also that all NIPERs should try to establish the National level testing labs for the pharma products as a source of revenue...

Lupin recalls a lot of Metformin Hydrochloride ER tablets in US over cancer-causing impurity

Ruchika Sharma12 Jun 2020 4:01 PM IST

Baltimore: Lupin Pharmaceuticals Inc. recently said that the company is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets USP...

Manufacturers to sell 20pc HCQ in domestic market, rest can be exported: Mansukh Mandaviya

Ruchika Sharma12 Jun 2020 2:46 PM IST

"When the COVID crisis started we had two units making Hydroxychloroquine, now we have 12 and production is more than the requirement. Hence, the...

Biocon, Mylan get USFDA approval for insulin glargine injection Semglee

Ruchika Sharma12 Jun 2020 1:17 PM IST

Semglee has an identical amino acid sequence to Sanofi's Lantus® and is approved for the same indications

Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension

Lupin gets USFDA nod to anthelmintic drug Albendazole

Ruchika Sharma12 Jun 2020 12:34 PM IST

Mumbai, Baltimore: Drug maker Lupin Limited has received approval for its Albendazole Tablets USP, 200 mg, from the United States Food and Drug...

DoP nod to lifting of ban on export of HCQ: D V Sadananda Gowda

Ruchika Sharma11 Jun 2020 1:50 PM IST

Manufacturers except SEZ/EOU Units have to supply 20 percent production in the domestic market," the minister of chemicals and fertilisers said in a...

Lupin, Ceek ink Marketing Agreement to Improve OB/GYN, Patient Experience with Nella Products

Ruchika Sharma11 Jun 2020 10:15 AM IST

The promotional arrangement includes detailing and demonstration of Ceek's products, alongside Lupin Ltd's women's health flagship product, Solosec...

Sandoz Canada gets approval to launch oncology biosimilars Ziextenzo, Riximyo

Ruchika Sharma11 Jun 2020 9:30 AM IST

Sandoz Canada received a Notice of Compliance from Health Canada on April 21, 2020, for the use of Ziextenzo to reduce the incidence of febrile...

COVID-19 Drug Trial: Arthritis, Cancer drug Namiluma, Infliximab tested in UK

Ruchika Sharma11 Jun 2020 9:15 AM IST

Izana Bioscience's Namiluma, a monoclonal antibody already in late-stage tests to treat rheumatoid arthritis and an inflammatory disease called...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok